Back to Search Start Over

The phenotypic spectrum of CEP250 gene variants.

Authors :
Courdier C
Dhaenens CM
Grunewald O
Guerrot AM
Audo I
Lecleire-Collet A
Amstutz-Montadert I
Gad S
Lapeyre G
Zanlonghi X
Bonneau D
Fradin M
Le Meur G
Marlin S
Blanc P
Roux AF
Meunier I
Michaud V
Source :
Ophthalmic genetics [Ophthalmic Genet] 2024 Nov 28, pp. 1-8. Date of Electronic Publication: 2024 Nov 28.
Publication Year :
2024
Publisher :
Ahead of Print

Abstract

Introduction: Classically, Usher syndrome is characterized by the association of sensorineural hearing loss (SNHL), retinitis pigmentosa (RP) and possible vestibular dysfunction. Pathogenic bi-allelic variants in CEP250 cause atypical autosomal recessive Usher syndrome, which is associated with SNHL and photoreceptors dysfunction without vestibular signs. To date, only 19 scattered descriptions have been reported. In this study, we present detailed clinical and genetic description of 7 unrelated individuals with CEP250 related disease, along with a literature review to provide new insight on the severity and course of the disease.<br />Methods: We retrospectively recruited 7 unrelated individuals who underwent genetic testing (targeted gene panel or whole genome sequencing) and were found to carry CEP250 pathogenic variants.<br />Results: Most patients (5/7) exhibit both retinal dystrophy and SNHL. Two patients appear to present either isolated hearing loss or visual impairment, but further investigations are needed to confirm a possible non-syndromic presentation. All patients harbored isolated truncating variants.<br />Discussion: CEP250 pathogenic variants are associated with post-lingual SNHL, and most often progressive photoreceptor dysfunction. The disease may begin with ocular features or hearing loss. We strongly recommend genetic analysis of classical and atypical Usher related-genes, in patients with isolated retinal dystrophy or SNHL. We also recommend ophthalmological evaluation and follow-up in patients with isolated SNHL, and conversely. The coexistence of loss- and gain-of-function effects may exist, complicating the development of gene therapy.

Details

Language :
English
ISSN :
1744-5094
Database :
MEDLINE
Journal :
Ophthalmic genetics
Publication Type :
Academic Journal
Accession number :
39610034
Full Text :
https://doi.org/10.1080/13816810.2024.2434045